Evidence map›Paper›PMID 39942685›Full record

ArticleMolecules (Basel, Switzerland)2025

Arrangement of Azidomethyl Group in Lupinine Azide: Structural and Spectroscopic Properties.

Kymbat Kopbalina, Dmitrii Pankin, Mikhail Smirnov, Niyazbek Ibrayev, Dastan Turdybekov

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kymbat KopbalinaDepartment of Physics and Nanotechnology, Buketov Karaganda University, Universitetskaya 28, Karaganda 100024, Kazakhstan.
Dmitrii PankinCenter for Optical and Laser Materials Research, St. Petersburg State University, Ulianovskaya 5, 198504 St. Petersburg, Russia.
Mikhail SmirnovFaculty of Physics, St. Petersburg State University, Universitetskaya Nab. 7/9, 199034 St. Petersburg, Russia.ORCID 0000-0002-4292-1989
Niyazbek IbrayevInstitute of Molecular Nanophotonics, Buketov Karaganda University, Universitetskaya 28, Karaganda 100024, Kazakhstan.
Dastan TurdybekovDepartment of Physics, Abylkas Saginov Karaganda Technical University, Ave. Nazarbayev 56, Karaganda 100027, Kazakhstan.ORCID 0000-0002-0245-022X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quinolizidine derivatives are an important class of substances that are used in the pharmaceutical industry. In previous studies, the synthesis of these substances is carried out using lupinine azide (IUPAC: 1-(azidomethyl)octahydro-2H-quinolizine), which is often used to obtain new biologically active compounds. In this regard, its structural characterization is critically important. In this work, the conformational diversity of the molecular structure of this compound has been studied. It is shown that the structure with the axial position of the methyl azide group contains a number of low-energy conformer states with energies higher than the ground state by 0.15-0.60 kcal/mol. Such structural ambiguity should manifest itself in the chemical reactions and biological activity of lupinine azide. The spectroscopic properties of the conformers were studied by modeling chemical shifts for carbon and hydrogen atoms, as well as by simulating IR absorption spectra. An analysis of the most specific spectroscopic features of all of the conformers was carried out. Based on the correlation of the theoretical results and the experimental spectroscopic data, a conclusion was made for the first time regarding the most probable conformational states in the solution.

Indexed as

azidesDFTIR absorbancelupinineNMRspectroscopy

Identifiers

PMID39942685
PMCPMC11820821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.